What evidence is good enough?

Nicola Robinson , Jian-ping Liu

Evidence-Based Chinese Medicine and Technology Assessment ›› 2025, Vol. 1 ›› Issue (3) : 9570016

PDF (663KB)
Evidence-Based Chinese Medicine and Technology Assessment ›› 2025, Vol. 1 ›› Issue (3) :9570016 DOI: 10.26599/eCMTA.2025.9570016
Editorial
research-article
What evidence is good enough?
Author information +
History +
PDF (663KB)

Keywords

evidence-based medicine / traditional Chinese medicine / GRADE / AGREE II / clinical guidelines / research evidence / case report

Cite this article

Download citation ▾
Nicola Robinson, Jian-ping Liu. What evidence is good enough?. Evidence-Based Chinese Medicine and Technology Assessment, 2025, 1 (3) : 9570016 DOI:10.26599/eCMTA.2025.9570016

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Fisher RA. Statistical Methods for Research Workers. 11th ed. rev. Edinburgh, UK: Oliver and Boyd; 1925.

[2]

Prasad M. Introduction to the GRADE tool for rating certainty in evidence and recommendations. Clin Epidemiol Glob Health. 2024; 25:101484.

[3]

Xun Y, Zhou Q, Yang N, et al. Clinical epidemiology in China series. Paper 2: promoting GRADE at the national level: the experience from China. J Clin Epidemiol. 2021; 140:172-177.

[4]

Liu JP.GRADE methods in traditional medicine. Integr Med Res. 2022; 11(2):100836.

[5]

Cao L, Yao L, Hui X, et al. Clinical epidemiology in China series. Paper 3: the methodological and reporting quality of systematic reviews and meta-analyses published by China' researchers in English-language is higher than those published in Chinese-language. J Clin Epidemiol. 2021; 140:178-188.

[6]

Brouwers MC, Kho ME, Browman GP, et al. AGREE II: advancing guideline development, reporting, and evaluation in healthcare. CMAJ. 2010;182:E839-E842.

[7]

Zhou Q, Wang Z, Shi Q, et al. Clinical epidemiology in China series. Paper 4: the reporting and methodological quality of Chinese clinical practice guidelines published between 2014 and 2018: a systematic review. J Clin Epidemiol. 2021; 140:189-199.

[8]

Robinson N, Liu J, Lee MS. Clinical guidelines: the way forward for integrated practice. Eur J Integr Med. 2014; 6(2):133-134.

[9]

Appleyard I, Lundeberg T, Robinson N. Should systematic reviews assess the risk of bias from sham-placebo acupuncture control procedures? Eur J Integr Med. 2014; 6(2):234-243.

[10]

Koppelman MH, Bovey M, Robinson N. Evidence is in the eye of the beholder: the case of the 2016 draft NICE guidelines for low back pain. Eur J Integr Med. 2016; 8(4):321-323.

[11]

Kmietowicz Z. Researchers’ focus on drugs over other treatments ignores doctors’ and patients’ views. BMJ. 2015;350:h3375.

[12]

Taha MJJ, Abuawwad MT. Integrating case reports into systematic reviews: methodological strategies and challenges. Syst Rev. 2025; 14(1):208.

[13]

Robinson KA, Brunnhuber K, Ciliska D, Juhl CB, Christensen R, Lund H. Evidence-based research series-paper 1: what evidence-based research is and why is it important? J Clin Epidemiol. 2021; 129:151-157.

[14]

Ma Y, Wang Q, Duan Y, et al. Promoting the quality and transparency of health research in China. J Clin Epidemiol. 2022; 152:209-217.

PDF (663KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉